Literature DB >> 10962349

Characterization of vitamin D receptor immunoreactivity in human bone cells.

M C Langub1, T A Reinhardt, R L Horst, H H Malluche, N J Koszewski.   

Abstract

The present study examined the expression of the vitamin D receptor (VDR) in adult human bone by immunohistochemical analysis. Antiserum from goats immunized with an N-terminal rat VDR peptide was purified by affinity chromatography. The purified antiserum recognized both endogenous rat and recombinant human VDR in Western blots. The purified antiserum was also able to specifically supershift the recombinant human VDR when analyzed in mobility shift assays. Immunohistochemical analysis of MG-63 cells, a human osteoblastic cell line known to express the VDR, revealed prominent staining over the nuclei of these cells. Immunostaining was greatly attenuated in the presence of an excess of the immunizing peptide. Analysis of bone biopsy samples from 16 normal human subjects immunostained for VDR protein showed strong, immunopositive staining over bone cells, particularly osteoblasts, in keeping with prior studies. In addition, there was significant immunoreactivity observed in nuclei of osteoclasts, lining cells and scattered bone marrow stromal cells of the adult human bone. Results showed that 298 osteoblasts out of 808 (36.9%) examined were immunopositive. It was also observed that 29 osteoclasts out of 125 (23%) contained VDR immunoreactivity. The ability to detect VDR in osteoclasts and stromal cell populations suggests that in addition to regulating osteoblast function, these other cell types are also direct targets of the hormone's action. These results demonstrate the utility of this purified antiserum in detecting the VDR in a variety of molecular techniques and should prove useful in examining receptor expression in various pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962349     DOI: 10.1016/s8756-3282(00)00335-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 2.  The Regulation of Marrow Fat by Vitamin D: Molecular Mechanisms and Clinical Implications.

Authors:  Hanel Sadie-Van Gijsen
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

3.  Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis.

Authors:  Peter F Schnatz; Matthew Nudy; David M O'Sullivan; Xuezhi Jiang; J Mark Cline; Jay R Kaplan; Thomas B Clarkson; Susan E Appt
Journal:  Menopause       Date:  2012-09       Impact factor: 2.953

Review 4.  Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials.

Authors:  Zhixing Xu; Changchun Fan; Xuechun Zhao; Hairong Tao
Journal:  Drug Des Devel Ther       Date:  2016-01-28       Impact factor: 4.162

5.  Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles.

Authors:  Jie Xu; Max D Kauther; Julia Hartl; Christian Wedemeyer
Journal:  J Orthop Surg Res       Date:  2010-11-04       Impact factor: 2.359

6.  The vitamin D analogue ED71 but Not 1,25(OH)2D3 targets HIF1α protein in osteoclasts.

Authors:  Yuiko Sato; Yoshiteru Miyauchi; Shigeyuki Yoshida; Mayu Morita; Tami Kobayashi; Hiroya Kanagawa; Eri Katsuyama; Atsuhiro Fujie; Wu Hao; Toshimi Tando; Ryuichi Watanabe; Kana Miyamoto; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

7.  Regulation of matrix metalloproteinase-9 protein expression by 1α, 25-(OH)₂D₃ during osteoclast differentiation.

Authors:  Jian-Hong Gu; Xi-Shuai Tong; Guo-Hong Chen; Xue-Zhong Liu; Jian-Chun Bian; Yan Yuan; Zong-Ping Liu
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.